New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells

New insights in gene expression alteration as effect of doxorubicin drug resistance in triple negative breast cancer cells

Abstract Background Triple negative breast cancer (TNBC) is a heterogeneous disease with aggressive behavior and an unfavorable prognosis rate. Due to the lack of surface receptors, TNBC must be intensely investigated in order to establish a suitable treatment for patients with this pathology. Chemo...

Full description

Bibliographic Details
Main Authors: Cristina Alexandra Ciocan-Cartita, Ancuta Jurj, Oana Zanoaga, Roxana Cojocneanu, Laura-Ancuta Pop, Alin Moldovan, Cristian Moldovan, Alina Andreea Zimta, Lajos Raduly, Cecilia Pop-Bica, Mihail Buse, Liviuta Budisan, Piroska Virag, Alexandru Irimie, Sandra Martha Gomez Diaz, Ioana Berindan-Neagoe, Cornelia Braicu
Format: Article
Language:English
Published: BMC 2020-11-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Triple negative breast cancer
Doxorubicin
Next-generation sequencing
Microarray
Drug resistance
Online Access:http://link.springer.com/article/10.1186/s13046-020-01736-2

Internet

http://link.springer.com/article/10.1186/s13046-020-01736-2

Similar Items